GYRE THERAPEUTICS INC

Ticker: GYRE CUSIP: 403783103 Class: Common Stock

CHARLES SCHWAB INVESTMENT MANAGEMENT INC's Holding History (CIK: 0000884546)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 169,158 Value ($000) $1,194 Avg Close $7.72 Range $6.90 - $9.42

Q3 2025

Shares 123,386 Value ($000) $920 Avg Close $7.59 Range $6.57 - $8.56

Q2 2025

Shares 129,420 Value ($000) $951 Avg Close $8.72 Range $6.11 - $11.78

Q1 2025

Shares 111,416 Value ($000) $860 Avg Close $10.97 Range $7.00 - $13.75

Q4 2024

Shares 114,566 Value ($000) $1,386 Avg Close $12.80 Range $9.54 - $19.00

Q3 2024

Shares 113,648 Value ($000) $1,425 Avg Close $12.89 Range $8.26 - $16.00

Q2 2024

Shares 23,091 Value ($000) $275 Avg Close $13.72 Range $8.90 - $17.49

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	169,158	$1,194	$7.72	$6.90 - $9.42
Q3 2025	123,386	$920	$7.59	$6.57 - $8.56
Q2 2025	129,420	$951	$8.72	$6.11 - $11.78
Q1 2025	111,416	$860	$10.97	$7.00 - $13.75
Q4 2024	114,566	$1,386	$12.80	$9.54 - $19.00
Q3 2024	113,648	$1,425	$12.89	$8.26 - $16.00
Q2 2024	23,091	$275	$13.72	$8.90 - $17.49